05/12/2019 |
Oasmia Pharmaceutical AB |
Anette Sjödin |
Vice VD |
|
Subscription |
Oasmia Pharmaceutical BTA 191118 |
BTA |
SE0013460557 |
04/12/2019 |
30,000 |
Quantity |
2.00 |
SEK |
|
Notification
|
04/12/2019 |
Oasmia Pharmaceutical AB |
Nina Heldring |
ledningsgruppsmedlem |
|
Acquisition |
Oasmia Pharmaceutical TR |
Subscription right |
SE0013460540 |
29/11/2019 |
15,105 |
Quantity |
1.70 |
SEK |
|
Notification
|
04/12/2019 |
Oasmia Pharmaceutical AB |
Nina Heldring |
ledningsgruppsmedlem |
|
Acquisition |
OASMIA PHARMACEUTICAL BTA |
BTA |
SE0002941799 |
29/11/2019 |
12,084 |
Quantity |
2.00 |
SEK |
|
Notification
|
04/12/2019 |
Oasmia Pharmaceutical AB |
Michael Carl Ewert af Winklerfelt |
Ekonomi/finanschef |
|
Subscription |
Oasmia Pharmaceutical AB BTA |
BTA |
SE0010101188 |
04/12/2019 |
37,760 |
Quantity |
2.00 |
SEK |
|
Notification
|
04/12/2019 |
Oasmia Pharmaceutical AB |
Gunilla Öhman |
Styrelseledamot/suppleant |
Yes |
Subscription |
Oasmia Pharmaceutical BTA 191118 |
BTA |
SE0013460557 |
04/12/2019 |
40,000 |
Quantity |
2.00 |
SEK |
|
Notification
|
29/11/2019 |
Oasmia Pharmaceutical AB |
Michael Carl Ewert af Winklerfelt |
Ekonomi/finanschef |
|
Acquisition |
Oasmia Pharmaceutical AB TR |
Subscription right |
SE0013460540 |
29/11/2019 |
5,367 |
Quantity |
1.74 |
SEK |
|
Notification
|
29/11/2019 |
Oasmia Pharmaceutical AB |
Michael Carl Ewert af Winklerfelt |
Ekonomi/finanschef |
|
Acquisition |
Oasmia Pharmaceutical AB TR |
Subscription right |
SE0013460540 |
29/11/2019 |
24,583 |
Quantity |
1.74 |
SEK |
|
Notification
|
28/11/2019 |
Oasmia Pharmaceutical AB |
Peter Zonabend |
Styrelseledamot/suppleant |
|
Subscription |
Oasmia Pharmaceutical AB BTA |
BTA |
SE0013460557 |
27/11/2019 |
500,000 |
Quantity |
2.00 |
SEK |
|
Notification
|
28/11/2019 |
Oasmia Pharmaceutical AB |
Sven Rohmann |
Board member and acting CEO |
|
Acquisition |
Oasmia Pharmaceutical AB - TR |
Subscription right |
SE0013460540 |
27/11/2019 |
300,000 |
Quantity |
1.453984 |
SEK |
|
Notification
|
28/11/2019 |
Oasmia Pharmaceutical AB |
Sven Rohmann |
Board member and acting CEO |
|
Acquisition |
Oasmia Pharmaceutical AB - TR |
Subscription right |
SE0013460540 |
27/11/2019 |
110,528 |
Quantity |
1.622 |
SEK |
|
Notification
|